As increased translation is a common feature of cancer (30), this provides a potential mechanism whereby normal stem cells would be relatively protected from CC-885 and potentially other drugs targeting GSPT1, providing additional rationale for GSPT1 as a clinical target. The gene discussed is GSPT1; the disease is cancer.